A detailed history of Advisory Services Network, LLC transactions in Altimmune, Inc. stock. As of the latest transaction made, Advisory Services Network, LLC holds 8,960 shares of ALT stock, worth $37,363. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,960
Previous 16,087 44.3%
Holding current value
$37,363
Previous $62,000 46.77%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 18, 2025

SELL
$3.38 - $4.76 $24,089 - $33,924
-7,127 Reduced 44.3%
8,960 $33,000
Q2 2025

Aug 19, 2025

BUY
$3.5 - $7.71 $40,250 - $88,665
11,500 Added 250.71%
16,087 $62,000
Q1 2025

May 15, 2025

BUY
$5.0 - $7.45 $22,935 - $34,173
4,587 New
4,587 $22,000
Q1 2024

May 06, 2024

BUY
$8.22 - $13.81 $218,257 - $366,683
26,552 Added 26552.0%
26,652 $271,000
Q4 2023

Feb 09, 2024

BUY
$2.14 - $11.62 $214 - $1,162
100 New
100 $1,000

Others Institutions Holding ALT

About Altimmune, Inc.


  • Ticker ALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,025,300
  • Market Cap $204M
  • Description
  • Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...
More about ALT
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.